THE PRESENCE OF BCL-1 AND BCL-2 GENE REARRANGEMENTS IN DIFFUSE SMALL CLEAVED-CELL LYMPHOMA - A DISEASE WITH DIVERSE MOLECULAR AND IMMUNOPHENOTYPIC FINDINGS
Cp. Leith et al., THE PRESENCE OF BCL-1 AND BCL-2 GENE REARRANGEMENTS IN DIFFUSE SMALL CLEAVED-CELL LYMPHOMA - A DISEASE WITH DIVERSE MOLECULAR AND IMMUNOPHENOTYPIC FINDINGS, Diagnostic molecular pathology, 3(3), 1994, pp. 178-183
Clonal rearrangements of the bcl-1 and bcl-2 protooncogenes are found
in many B-lineage non-Hodgkin's lymphomas (NHL) and may play a role in
their pathogenesis. We investigated rearrangements of the bcl-1 and b
cl-2 protooncogenes in 13 cases of B lineage diffuse small cleaved-cel
l lymphoma (DSCL), and correlated the results with clinical history, i
mmunophenotype, and outcome. Six cases showed bcl-2 rearrangements, in
cluding four patients with an antecedent follicular small cleaved-cell
lymphoma (FSCL). Two patients had a bcl-1 rearrangement, including on
e with a previous FSCL. Of the five patients who lacked detectable bcl
-1 or bcl-2 rearrangements, one had an FSCL history. Similar to the la
ck of correlation between clinical history and genotype, there was no
correlation between genotype and immunophenotype. Our results indicate
that although DSCL is a morphologically uniform disease, different mo
lecular genetic pathways are involved in its genesis. Follow-up showed
four of the six DSCL patients with bcl-2 rearrangements were alive wi
th a median survival of 56 months, whereas the median survival of the
seven patients lacking a bcl-2 rearrangement was 17 months and include
d only one survivor. Thus bcl-2 rearrangements in DSCL may define a pa
tient subset with a more indolent genetic abnormality and prolonged su
rvival.